Literature DB >> 20347501

The place of liver transplantation in the treatment of severe alcoholic hepatitis.

Parul Dureja1, Michael R Lucey.   

Abstract

Although most patients with alcoholic liver disease experience positive outcomes following liver transplantation, data on the outcome after liver transplantation in patients with severe alcoholic hepatitis are limited. Furthermore, predicting which patients with severe alcoholic hepatitis will maintain sobriety after transplantation is especially difficult. We review the arguments in favour and against extending liver transplantation to selected patients with severe alcoholic hepatitis. In conclusion, we propose that liver transplantation should be a rescue option for occasional patients with severe alcoholic hepatitis who meet the following criteria: those with severe alcoholic hepatitis that has failed medical management, who fulfil all other standard criteria for transplantation, including a thorough psychosocial assessment, yet who are unlikely to survive a mandatory 6-month abstinence period. Copyright (c) 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347501     DOI: 10.1016/j.jhep.2009.12.021

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  19 in total

1.  Liver transplantation in acute alcoholic hepatitis: Current status and future development.

Authors:  Ashwani K Singal; Andrea Duchini
Journal:  World J Hepatol       Date:  2011-08-27

Review 2.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

3.  A Day-4 Lille Model Predicts Response to Corticosteroids and Mortality in Severe Alcoholic Hepatitis.

Authors:  Mauricio Garcia-Saenz-de-Sicilia; Chitharanjan Duvoor; Jose Altamirano; Roberta Chavez-Araujo; Veronica Prado; Ana de Lourdes Candolo-Martinelli; Patricia Holanda-Almeida; Bernardo Becerra-Martins-de-Oliveira; Simony Fernandez-de-Almeida; Ramón Bataller; Juan Caballeria; Andres Duarte-Rojo
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864

4.  Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).

Authors:  Sandeep Singh Sidhu; Omesh Goyal; Preeti Singla; Dinesh Gupta; Ajit Sood; Rajoo Singh Chhina; Ravinder Kumar Soni
Journal:  Dig Dis Sci       Date:  2012-03-03       Impact factor: 3.199

Review 5.  Pharmacotherapy of acute alcoholic hepatitis in clinical practice.

Authors:  Ludovico Abenavoli; Natasa Milic; Samir Rouabhia; Giovanni Addolorato
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 6.  Ethical issues associated with solid organ transplantation and substance use: a scoping review.

Authors:  Lauren Notini; Denitsa Vasileva; Ani Orchanian-Cheff; Daniel Z Buchman
Journal:  Monash Bioeth Rev       Date:  2019-12

Review 7.  Alcoholic liver disease: pathogenesis and new therapeutic targets.

Authors:  Bin Gao; Ramon Bataller
Journal:  Gastroenterology       Date:  2011-09-12       Impact factor: 22.682

Review 8.  Alcoholic liver disease: treatment.

Authors:  Ki Tae Suk; Moon Young Kim; Soon Koo Baik
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 9.  [Acute liver failure. How much diagnostic work-up and therapy does my patient need?].

Authors:  J Hadem; A S Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

10.  Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway.

Authors:  Zhi Zhang; Huiqing Wen; Jun Weng; Lei Feng; Hongya Liu; Xiaojun Hu; Fanhong Zeng
Journal:  Cell Cycle       Date:  2019-08-05       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.